(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis patients, following ...
Feb 26, 2013
0
0
A new systematic review and meta-analysis has found that alcohol-targeted brief interventions (short, structured, one-to-one conversations about drinking designed to motivate changes in risky behaviour) delivered in doctors' ...
Oct 14, 2021
0
2
Heart failure patients who are moderately or severely depressed have four times the risk of dying and double the risk of having to go to the emergency room or be hospitalized compared to those who are not depressed, according ...
Mar 19, 2013
0
0
(HealthDay)—Use of drug-eluting stents (DES) rather than bare-metal stents (BMS) for percutaneous coronary intervention (PCI) is associated with lower rates of in-hospital mortality, according to research published in the ...
Nov 20, 2014
0
0
More young people are turning to marijuana as their first substance of choice, rather than smoking cigarettes or drinking alcohol. This pattern is especially prevalent among young men of specific racial and ethnic groups ...
May 17, 2018
0
4
A report on interventional cardiology practice from an extensive survey is presented today at EuroPCR 2018, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), a branch of ...
May 22, 2018
0
2
Not only is alcohol one of the world's most abused drugs, but alcohol-related deaths trail only tobacco, poor diet and physical activity, and illegal drugs as the leading cause of preventable deaths in the United States.
Jun 13, 2023
0
2
An intervention consisting of clinician education coupled with personalized audit and feedback about antibiotic prescribing improved adherence to prescribing guidelines for common pediatric bacterial acute respiratory tract ...
Jun 11, 2013
0
0
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes ...
Sep 1, 2013
0
0
A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians ...
Oct 1, 2012
0
0
